Verbeek A - Search Results

1

Minor influence of self-selection bias on the effectiveness of breast cancer screening in case-control studies in the Netherlands.

Paap E, Verbeek A, Puliti D, Broeders M, Paci E. Paap E, et al. Among authors: verbeek a. J Med Screen. 2011;18(3):142-6. doi: 10.1258/jms.2011.011027. J Med Screen. 2011. PMID: 22045823

2

Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review.

Otto SJ, Fracheboud J, Looman CW, Broeders MJ, Boer R, Hendriks JH, Verbeek AL, de Koning HJ; National Evaluation Team for Breast Cancer Screening. Otto SJ, et al. Lancet. 2003 Apr 26;361(9367):1411-7. doi: 10.1016/S0140-6736(03)13132-7. Lancet. 2003. PMID: 12727393 Review.

3

Spouse controls in family case-control studies: a methodological consideration.

Verhage BA, Aben KK, Straatman H, Verbeek AL, Beaty TH, Kiemeney LA. Verhage BA, et al. Among authors: verbeek al. Fam Cancer. 2003;2(2):101-8. doi: 10.1023/a:1025737025219. Fam Cancer. 2003. PMID: 14574159

4

Estimating life expectancy and related probabilities in screen-detected breast cancer patients with restricted follow-up information.

Straatman H, Verbeek AL, Peer PG, Borm G. Straatman H, et al. Stat Med. 2004 Feb 15;23(3):431-48. doi: 10.1002/sim.1539. Stat Med. 2004. PMID: 14748037

5

Impressive time-related influence of the Dutch screening programme on breast cancer incidence and mortality, 1975-2006.

Otten JD, Broeders MJ, Fracheboud J, Otto SJ, de Koning HJ, Verbeek AL. Otten JD, et al. Int J Cancer. 2008 Oct 15;123(8):1929-34. doi: 10.1002/ijc.23736. Int J Cancer. 2008. PMID: 18688863

6

League tables of breast cancer screening units: worst-case and best-case scenario ratings helped in exposing real differences between performance ratings.

Lemmers O, Broeders M, Verbeek A, Heeten Gd, Holland R, Borm GF. Lemmers O, et al. Among authors: verbeek a. J Med Screen. 2009;16(2):67-72. doi: 10.1258/jms.2009.008093. J Med Screen. 2009. PMID: 19564518

7

Life expectancy of screen-detected invasive breast cancer patients compared with women invited to the Nijmegen screening program.

Otten JD, Broeders MJ, Den Heeten GJ, Holland R, Fracheboud J, De Koning HJ, Verbeek AL. Otten JD, et al. Cancer. 2010 Feb 1;116(3):586-91. doi: 10.1002/cncr.24771. Cancer. 2010. PMID: 19998346 Free article.

8

Evaluation of cancer service screening: case referent studies recommended.

Verbeek AL, Broeders MJ. Verbeek AL, et al. Stat Methods Med Res. 2010 Oct;19(5):487-505. doi: 10.1177/0962280209359856. Epub 2010 Mar 31. Stat Methods Med Res. 2010. PMID: 20356858

9

A remarkable reduction of breast cancer deaths in screened versus unscreened women: a case-referent study.

Paap E, Holland R, den Heeten GJ, van Schoor G, Botterweck AA, Verbeek AL, Broeders MJ. Paap E, et al. Among authors: verbeek al. Cancer Causes Control. 2010 Oct;21(10):1569-73. doi: 10.1007/s10552-010-9585-7. Epub 2010 May 30. Cancer Causes Control. 2010. PMID: 20512656

10

Colorectal cancer screening comparing no screening, immunochemical and guaiac fecal occult blood tests: a cost-effectiveness analysis.

van Rossum LG, van Rijn AF, Verbeek AL, van Oijen MG, Laheij RJ, Fockens P, Jansen JB, Adang EM, Dekker E. van Rossum LG, et al. Int J Cancer. 2011 Apr 15;128(8):1908-17. doi: 10.1002/ijc.25530. Int J Cancer. 2011. PMID: 20589677 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

476 results

Search Page

Filters